Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence

Oncology Reports

Volumn 11, Issue 5, 2004, Pages 1107-1113

  Seelig, Matthias H ^a   Leible, Meike ^b   Sänger, Jan ^b   Berger, Martin R ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

5 fluorouracil; CC531 lac Z; Chemiluminescence; Chemoembolization; Gemcitabine; Liver metastasis; Tumor model; galactosidase

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; GEMCITABINE; MICROSPHERE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CHEMOEMBOLIZATION; COLON TUMOR; DISEASE MODEL; LIVER TUMOR; MALE; METASTASIS; ORGAN SIZE; PATHOLOGY; RAT; RAT STRAIN; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; COLONIC NEOPLASMS; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; FLUOROURACIL; LIVER NEOPLASMS; MALE; MICROSPHERES; NEOPLASM TRANSPLANTATION; ORGAN SIZE; RATS; RATS, INBRED STRAINS; TUMOR BURDEN;

EID: 16544386989     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.5.1107     Document Type: Article

References (30)

1. Tanigushi H, Takahashi T, Yamagushi T and Sawai K: Intraarterial infusion chemotherapy for metastatic liver tumors using multiple anticancer agents suspended in a Lipiodol contrast medium. Cancer 64: 2001-2006, 1989. (Pubitemid 19280394)
2. Lang EK and Brown CL: Colorectal metastases to the liver. Selective chemoembolization. Radiology 189: 417-422, 1993. (Pubitemid 23321421)
3. Kameyama M, Imaoka S, Fukuda I, et al: Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastases of colorectal cancer. Surgery 114: 97-101, 1993. (Pubitemid 23209349)
4. Tellez C, Benson AB, Lyster MT, et al: Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82: 1250-1259, 1998. (Pubitemid 28155386)
5. Leichman CG, Jacobson JR, Modiano M, et al: Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial. Cancer 86: 775-781, 1999. (Pubitemid 29399916)
6. Salman HS, Cynamon J, Jagust M, et al: Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2: 173-179, 2002. (Pubitemid 36013668)
7. Voigt W, Behrmann C, Schlueter A, Kegel T, Grothey A and Schmoll HJ: A new chemoembolization protocol in refractory liver metastasis of colorectal cancer - a feasibility study. Onkologie 25: 158-164, 2002. (Pubitemid 34507665)
8. Li X, Zheng CS, Feng GS, Zhuo CK, Zhao JG and Liu X: An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features. W J Gastroenterol 15: 1035-1039, 2002. (Pubitemid 35446416)
9. Trübenbach J, Graepler F, Pereira PL, et al: Growth characteristics and imaging properties of the Morris hepatoma 3924A in ACI rats: a suitable model for transarterial chemoembolization. Cardiovasc Intervent Radiol 23: 211-217, 2000. (Pubitemid 30421901)
10. Wittmer A, Khashayarsha K and Berger MR: Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model. Clin Exp Metast 17: 369-376, 1999. (Pubitemid 30019994)
11. Noble S and Goa KL: Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 54: 447-472, 1997. (Pubitemid 27395596)
12. Mani S, Kugler JW, Knost JA, et al: Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer. Invest New Drugs 16: 275-278, 1999.
13. Kornmann M, Butzer U, Blatter J, Beger HG and Link KH: Preclinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer. Eur J Surg Oncol 26: 583-587, 2000.
14. Forsberg JO: Transient blood flow reduction induced by intraarterial injection of degradable starch microspheres. Act Chir Scand 144: 275-281, 1978.
15. Civalleri D, Esposito M, Fulco R, et al: Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer 68: 988-994, 1991.
16. Thom AK, Sigurdson ER, Bitar M and Daly JM: Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake. Surgery 105: 383-392, 1989. (Pubitemid 19076427)
17. Marquet RL, Westbroek DL and Jeekel J: Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site. Int J Cancer 33: 689-692, 1984. (Pubitemid 14141521)
18. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
19. Sobottka SB and Berger MR: Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties. Cancer Chemother Pharmacol 30: 385-393, 1992.
20. Saltz LB, Cox JV, Blamke C, et al: Irinotecan plus fluorouracil and leukovorin for metastatic colorectal cancer. N Engl J Med 343: 905-914, 2000.
21. Venditti JM, Wesley RA and Plowman J: Current NCI preclinical antitumor screening in vivo: results tumor panel screening, 1976-1982, and future directions. Adv Pharmacol Chemother 20: 1-20, 1984. (Pubitemid 14096153)
22. Rozycki-Gerlach W, Berger MR, Friedl P, Yi J, Schmähl D and Schlag P: First experiments with locoregional chemotherapy in the treatment of autochthonous rat hepatoma. Arch Geschwulstforschung 58: 369-378, 1988. (Pubitemid 19013726)
23. Bartkowski R, Berger MR, Aguiar JL, et al: Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2′-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. J Cancer Res Clin Oncol 111: 42-46, 1986. (Pubitemid 16161966)
24. Kamphorst EJ, Bödeker H, Koroma S, Linnemann U and Berger MR: New technique for superselective arterial (chemo-) embolization of the rat liver. Lab Anim Sci 49: 216-219, 1999. (Pubitemid 29207291)
25. Griffini P, Smorenburg SM, Verbeek FJ and van Noorden CJ: Three-dimensional reconstruction of colon carcinoma metastases in the liver. J Microsc 187: 12-21, 1997. (Pubitemid 27319865)
26. Taylor I, Bennett R and Sherriff S: The blood supply of colorectal liver metastases. Br J Cancer 8838: 749-756, 1978. (Pubitemid 9086487)
27. Civalleri D, Scopinaro G, Balletto N, et al: Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres. Br J Surg 76: 699-703, 1989. (Pubitemid 19188777)
28. Pohlen U, Berger G, Binnenhei M, Reszka R and Buhr HJ: Increased Carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam): an experimental study in tumor-bearing rabbits. J Surg Res 92: 165-200, 2000.
29. Germer CT, Isbert C, Albrecht D, et al: Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Ann Surg 230: 55-62, 1999. (Pubitemid 30190365)
30. Ruiz van Haperen VW, Veerman G, Boven E, Noordhuis P, Vermorken JB and Peters GJ: Schedule dependence of sensitivity to 2′,2′- difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours. Biochem Pharmacol 48: 1327-1339, 1994.